Cellular reprogramming of glioma cells into neural cells may be a promising treatment for glioblastoma brain cancer.
While incidence rates of malignant brain cancers have declined over recent years, the five-year survival rate for brain cancer patients remains low.
Researchers found lymph-node-like structures close to glioma brain tumors in cancer patients. The study reveals immune cells within these structures can be activated to attack the brain tumor.
Researchers have carried out clinical trials to test a mutation-specific vaccine against malignant brain tumors. The vaccine has been found to be safe and effective in triggering the desired immune response in the brain cancer tumors.
Researchers have developed a Dp44mT nano-carrier that can directly target glioblastoma and other brain cancer cells.
A new zebrafish model holds the potential for future studies of glioblastoma, an aggressive and lethal brain cancer.
Artificial IntelligenceBrain CancerDeep LearningFeaturedMachine LearningNeurologyNeuroscienceNeurotech··3 min read
A new machine learning algorithm can predict which tumors were lower-grade gliomas or glioblastoma brain cancer with a high degree of accuracy.
A new, freely available computer platform creates a 3D model that brings together the macroscopic scale of tissue with the microscopic scale of individual cells. This allows the platform to realistically model brain cancer's mechanobiology while maintaining resolution power.